Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Renin granules from rat kidney prepared at 25 degrees C show greater stability at 25 degrees C than at 0 degrees C when incubated in ionic medium. The sum of the
renin
in the supernatant fluid plus that in the pellet was the same at 25 degrees C as at 0 degrees C, thus ruling out the possibility that the extra release at 0 degrees C merely represented greater stability of free
renin
at 0 degrees C. In common with other secretory granules,
renin
granules were most stable at pH 6.0 and were osmotically sensitive. In contrast to neurosecretory and chromaffin granules,
renin
granules were stabilized by Mg-ATP in ionic medium. This result is similar to studies by others on lysosomes. It is concluded that the
renin
granules membrane shares many of the properties of other granule membranes. Some of these properties (temperature and pH lability) will have to be considered in the design of future experiments on
renin
storage and release.
Mol
Cell Endocrinol 1976 Oct
PMID:Properties of renin granules isolated from rat kidney. 1 Feb 15
1. The morphology of the juxtaglomerular apparatus, plasma
renin
activity, plasma
renin
substrate and renal
renin
have been studied in rats after maximal stimulation by bilateral adrenalectomy and salt depletion, and also after blocking this stimulation by deoxycorticosterone and salt load. 2. After stimulation the juxtaglomerular apparatus showed a well-developed granular endoplasmic reticulum and a low secretory granule content. Plasma
renin
activity was markedly elevated and plasma
renin
substrate was low. After blockade numerous specific granules with crystalline structures were seen and the granular endoplasmic reticulum was less developed. Plasma
renin
activity was now low and plasma
renin
substrate elevated. 3. After prior acidification of the kidney extract a significant increase of renal
renin
was observed in both conditions but was greater in the second group at the time when large numbers of young granules containing crystalline material were seen. 4. Kidney slices from the adrenalectomized salt-depleted rats released more
renin
than control slices. Vincristine did not affect this release, but inhibited release from slices stimulated by isoprenaline.
Clin Sci
Mol
Med Suppl 1976 Dec
PMID:Control of renin secretion in vivo and in vitro in rats: arguments in favour of a precursor form of renin and of a role of a microtubular system. 1 63
1. Inactive
renin
, which can be converted into an active form by acidification to pH 3-3, represents 4-63% of the total
renin
in rat peripheral plasma. 2. No inactive component could be found in the blood-free venous effluent of the perfused rat kidney before and after stimulation with isoprenaline. 3. This suggests a possible extrarenal source for inactive
renin
and may explain the presence of this component in anephric patients.
Clin Sci
Mol
Med 1977 Aug
PMID:Evidence that 'inactive' renin is produced outside the kidney of the rat. 1 91
1. The properties of inactive and active
renin
in human plasma and amniotic fluid were studied chromatographically. Activation was achieved at pH 3.3 with and without added pepsin. 2. Acid activation of
renin
was time- and temperature-dependent but was inhibited by dilution of the sample. The dilution effect was corrected by adding pepsin. Such characteristics indicate that activation at low pH is catalysed by intrinsic enzymes. 3. Separation and/or dilution of the activating enzyme during ion-exchange chromatography concealed the eluted position of inactive
renin
and reduced the amount recovered. Only after full activation of the eluted
renin
was achieved with added pepsin was a distinct peak of inactive
renin
exposed. 4. At pH 7.5 inactive
renin
carried a lower negative charge than the active enzyme. This charge difference was lost after activation. 5. No molecular-weight differences between active, inactive
renin
or the International Renin Standard were detected by gel filtration. No
renin
of larger molecular weight was present. 6. These findings will be helpful in purification studies of human inactive
renin
.
Clin Sci
Mol
Med 1978 Jul
PMID:The nature of inactive renin in human plasma and amniotic fluid. 2 28
1. Plasma
renin
activity (PRA) and mean blood pressure were studied in conscious rabbits infused with beta-adrenoreceptor antagonists. 2. Oxprenolol and DL-propranolol each significantly reduced PRA and blood pressure, but prindolol, which had a strong blood pressure-lowering effect, increased PRA. 3. When prindolol was given to animals in which PRA and blood pressure had been reduced by DL-propranolol, PRA returned to control values but blood pressure remained low. Thus the increase in PRA caused by prindolol is not mediated by hypotension. These findings, together with the observation that compound H35/25 reduced PRA without altering blood pressure, suggest that the effects of the beta-adrenoreceptor-blocking drugs on blood pressure are unrelated to their effects on
renin
release. 4. Studies with D-propranolol and with blocking agents with either beta-1 or beta-2 specificity indicated that the effects of beta-adrenoreceptor blockade on
renin
are directly dependent upon their action on beta-adrenergic receptors, probably of the beta-2 type.
Clin Sci
Mol
Med Suppl 1975 Jun
PMID:beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit. 2 80
1. Angiotensin I-generating activity of rat brain extract was separated into two components by affinity chromatography on a casein-Sepharose gel column. 2. The component without affinity to the gel was identified as true
renin
on the basis of its sensitivity to anti-
renin
antibody and the lack of protease activity. 3. The second
renin
-like component with affinity to the gel was a protease insensitive to the anti-
renin
antibody. Its
renin
-like activity examined with sheep substrate was pronounced compared with the rate of angiotensin I generation from the rat substrate. 4. It was concluded that rat brain contains true
renin
, which can be detected by the use of rat substrate but can be masked when examined with sheep substrate.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Definitive evidence for renin in rat brain by affinity chromatographic separation from protease. 3 1
1. Active and acid-activable inactive
renin
were measured in renal venous and arterial plasma of 18 patients with essential hypertension (EHT) and 19 patients with renovascular hypertension (RVHT). In seven patients with EHT and in 11 patients with RVHT measurements were made before and 25-35 min after an intravenous injection of 300 mg of diazoxide. 2. Under basal conditions the renal vein to artery ratios for active and inactive
renin
in EHT ranged from 0.71 to 1.96 and from 0.68 to 1.44 respectively. In 14 patients with RVHT the renal vein to artery ratio for active
renin
on the affected side was above the range found in EHT and in six of them the renal vein to artery ratio for inactive
renin
was also elevated. 3. The diazoxide-induced release of active
renin
from kidneys, which had a stenotic artery but were not seriously contracted, was associated with a fall of the renal vein to artery ratio for inactive
renin
to a value below 1.00. 4. The results indicate that changes in the release of active and inactive
renin
do not always run in parallel. The findings are compatible with the hypothesis that circulating inactive
renin
can be activated in the kidney.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Renal release of active and inactive renin in essential and renovascular hypertension. 3 2
1. The protease inhibitors Trasylol and soyabean trypsin inhibitor prevented the activation of plasma inactive
renin
by acid. 2. N-Ethylmaleimide inhibited acid-activation to some extent but o-phenathroline had no effect. 3. Acid-activation of the inactive
renin
in human plasma is mediated by a serine protease.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:An endogenous protease activating plasma inactive renin. 3 3
1. We have found that 'acid'-activation of inactive human plasma
renin
is a two-phase process. About 30% of activation occurs during dialysis to pH 3.3; the remaining 70% occurs at alkaline pH. 2. The 'alkaline phase' of activation has a pH optimum between 7.5 and 8.4. It is inhibited by unacidified plasma and by soya-bean or lima-bean trypsin inhibitors. 3. 'Cryoactivation' of inactive plasma
renin
, which occurs at -4 degrees C and alkaline pH, is also inhibited by soya-bean or lima-bean trypsin inhibitors and by the serine protease inhibitors diisopropylphosphorofluoridate and benzamidine. 4. Thus endogenous neutral serine proteases participate in the activation of inactive plasma
renin
in vitro. Their action is prevented in the circulation by inhibitors which are inactivated by acid or cold.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Activation of inactive plasma renin: evidence that both cryoactivation and acid-activation work by liberating a neutral serine protease from endogenous inhibitors. 3 4
1. The capacity of various tissues of the porcine kidney to convert [1-14C]arachidonic acid into radiolabelled prostaglandins was studied. 2. Only after removal from the cortical matrix, were renal blood vessels able to convert arachidonic acid into prostaglandins (primarily prostacyclin). In contrast, convoluted tubules showed a low capacity to metabolize arachidonic acid. 3. The failure to demonstrate prostaglandin synthesis by renal cortical slices is related to the presence of an inhibitor of cyclo-oxygenase. Thus the addition of renal cortical incubate to isolated vascular tissues and ram seminal vesicles inhibited their ability to synthesize prostaglandins. 4. Slices of renal medulla metabolized arachidonic acid primarily to prostaglandin F2alpha; lesser amounts of prostaglandin E2 and prostacyclin were generated. 5. The large capacity of the renal vasculature to generate prostacyclin is consistent with an important role for this prostaglandin in regulation of
renin
release and renal haemodynamics.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Endogenous prostaglandin synthesis inhibitor in the renal cortex. Effects on production of prostacyclin by renal blood vessels. 10 75
1
2
3
4
5
6
7
8
9
10
Next >>